The Ministry for Health is proposing removing 456 medicaments from public financing as part of the cuts in the health service. The objective is to save 440 million € on medicaments which treat ‘lesser symptoms’. Some medicines which will no longer be financed will be Almax, (for stomach acidity) Voltaren (for trauma) or Acetilcisteína (for the treatment of catarrh). Commonly used medicaments such as ibuprofen or paracetamol will continue to be financed. The Ministry of Health and the Regional Health Authorities will meet later today, Wednesday to discuss the list. The plan is that doctors can prescribe what they wish, but if it is on the excluded list the patient will have to pay for entire cost of the medicine. Here is a Google translation of the areas where drugs will no longer be paid for by the health service. Treatment of excess gastric secretions (aluminum compounds, combinations of complexes of aluminum). Treatment of constipation (laxatives generating volume, osmotic laxatives, opioid-receptor antagonists peripheral opioid-). Antidiarrheal treatments (prepared coal-loperamina antipropulsivos-) Migraine Treatment-classical treatment of mild migraine, (Ergot alkaloids-ergot-). Treatment of cognitive impairment associated with age (peripheral vasodilator, vincamine, vinburmina, buflomedil, naftidrofuryl-). Hemorrhoid treatments (corticosteroids (flucinolona, beclomethasone). Treatment of varicose veins and hemorrhoids (Bioflavoniods-diosmin, troxerutin, hidrosmin, rutoside, escin). Diaper rash treatments (creams with low doses of imidazole derivative miconazole-). Treatment of psoriasis (calaguala extract). Topical treatments or viral surface (idoxuridine, tromantadina, acyclovir, podophyllotoxin, imiquimod). Topical treatments for traumatic inflammation (topical NSAIDs (etofenamate, piroxicam, ketoprofen, diclofenac, niflumic acid, Suxibuzone, indomethacin, aceclofenac, phenylbutazone, benzydamine mabruprofeno, desketoprofeno, piketoprofen, fepradinol)
Subscribe to:
Post Comments (Atom)
Post a Comment